Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-UK begins rollout of Moderna COVID vaccine as daily rollout slows

Wed, 07th Apr 2021 06:56

* UK begins using Moderna's shot

* UK daily rollout slows to lowest level this year

* PM Johnson: Get a shot
(Adds context)

By Guy Faulconbridge and Kate Holton

LONDON, April 7 (Reuters) - Britain begins using Moderna's
COVID-19 vaccine on Wednesday in Wales just as its rollout of
other shots has fallen to its lowest level this year due to a
supply crunch caused by manufacturing problems at AstraZeneca.

Britain has surged ahead of the rest of Europe in the race
to vaccinate its population, with almost half of its citizens
receiving a first dose, but supply issues from its main
Oxford-AstraZeneca shot have slowed progress in recent
days.

Britain distributed almost 96,000 shots on Sunday and just
over 105,000 on Monday, the lowest figures since the government
started publishing daily numbers in January.

British ministers had warned the rollout would slow in April
due to AstraZeneca's manufacturing issues, including at a site
in India.

"The Moderna vaccine rollout begins today, starting with
Carmarthen in Wales," Prime Minister Boris Johnson said. "We
have ordered 17 million doses that will be going into arms
across the UK in the coming weeks.

"Please get your jab as soon as you are contacted."

Moderna, whose shots are already being used in the United
States and other parts of Europe, will become the third vaccine
to be used in Britain after the AstraZeneca shot and one from
Pfizer-BioNTech .

It uses the same mRNA technology as Pfizer's shot but can be
stored at normal fridge temperatures unlike its rival U.S.
vaccine, which must be stored and shipped at ultra-cool
temperatures.

Junior business minister Paul Scully told Sky News the
Moderna shot would reach the rest of the United Kingdom in the
coming days.

"You've heard the vaccine minister Nadhim Zahawi talking
about the third week of April. We're already just about to start
the second week of April so that's not too long to wait."

The United Kingdom has vaccinated 31.6 million people with a
first dose of a COVID-19 vaccine - and administered 5.5 million
second doses. In recent weeks, cases, hospitalisations and
deaths have all fallen.

Israel is the world leader in vaccinating its population
against COVID-19, followed by the United Arab Emirates, Chile,
the United Kingdom, the United States, Bahrain, Serbia and
Hungary, according to Our World in Data.
(Reporting by Guy Faulconbridge and Costas Pitas; Editing by
William Schomberg and Mark Potter)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.